NetTargets, (주)넷타겟
Mechanism matters
Korea South
22 employees
Series A
Total: $8.00B
AI, Biotechnology +1
General Information
Korea South
BounceWatch is an independent company data service, not affiliated with NetTargets, (주)넷타겟. To contact NetTargets, (주)넷타겟, visit net-targets.com.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
How does NetTargets, (주)넷타겟 compare?
A PDF of NetTargets, (주)넷타겟 and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Meeting NetTargets, (주)넷타겟 soon?
A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample
Discover More
About NetTargets, (주)넷타겟
Business keywords: drug discovery, systems biology, research institute, KAIST, expertise, spinout company, first-in-class drug development, cutting-edge technology, novel drug targets, AI-enhanced systems biology, promising, deep knowledge, experience
Funding Rounds & Investors (3)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Series A | KRW6.00B | 6 |
|
02 Jul 2021 |
| Seed Round | KRW2.00B | 1 |
|
20 Jan 2020 |
| Seed Round | Undisclosed | 2 |
-logo.jpg){kind=logo}
|
01 Oct 2019 |
NetTargets, (주)넷타겟 Alternatives & Competitors
View All Alternatives
Unlocking clinical insights by decoding intricate multi-omic patterns.
FAQ About NetTargets, (주)넷타겟
Source: BounceWatch company record for NetTargets, (주)넷타겟, https://bouncewatch.com/company/nettargets, updated 21 October 2024. When citing, please name BounceWatch and link this page.
